Masahiko Wada
About
In The Last Decade
Masahiko Wada
27 papers receiving 451 citations
Peers
Comparison fields: 5 of 80
- Epidemiology 163
- Surgery 111
- Molecular Biology 109
- Oncology 69
- Nephrology 58
Countries citing papers authored by Masahiko Wada
This map shows the geographic impact of Masahiko Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Wada more than expected).
Fields of papers citing papers by Masahiko Wada
This network shows the impact of papers produced by Masahiko Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Wada. The network helps show where Masahiko Wada may publish in the future.
Co-authorship network of co-authors of Masahiko Wada
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Wada. A scholar is included among the top collaborators of Masahiko Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Wada. Masahiko Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 14 | |
| 4 | 54 | |
| 5 | 40 | |
| 6 | 7 | |
| 7 | 15 | |
| 8 | 3 | |
| 9 | [Predictive analysis for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis]. | 3 |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 24 | |
| 13 | 9 | |
| 14 | 61 | |
| 15 | 45 | |
| 16 | The Usefulness of Combination Therapy with Preprandial Rapid-Acting Insulin Injections and .ALPHA.-Glucosidase Inhibitor in non-obese NIDDM Patients with Secondary Failure on Oral Hypoglycemic Agents. | 2 |
| 17 | 4 | |
| 18 | 5 | |
| 19 | Isolation and Characterization of a Methanol-assimilating Yeast, Condida methanophilum sp.nov. : Study on the Fermentation of Methanol as a Sole Carbon Source(II). | 2 |
| 20 | Isolation and Characterization of a Gram-positive Methoanol Assimilating Bacterium : Study on the Fermentation of Methanol as a Sole Carbon Source (I) | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.